ALYKA Health Technologies, LLC – Trademark Portfolio
Entity Type: 16
ALYKA Health Technologies, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ALYKA and ALYKA HEALTH TECHNOLOGIES. The owner is based in Marietta, GA.
920 Saint Lyonn Courts
Marietta, GA 30068
Showing of trademarks Trademarks
Trademark Classifications
ALYKA Health Technologies, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ALYKA Health Technologies, LLC have?
ALYKA Health Technologies, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does ALYKA Health Technologies, LLC file in?
ALYKA Health Technologies, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ALYKA Health Technologies, LLC's most well-known trademarks?
ALYKA Health Technologies, LLC's registered trademark portfolio includes well-known marks such as ALYKA and ALYKA HEALTH TECHNOLOGIES. These are among 3 currently registered trademarks in the portfolio.
What is ALYKA Health Technologies, LLC's trademark registration success rate?
ALYKA Health Technologies, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.